18 Programs
-
Defining the Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Breast Cancer — Issue 1
-
-
E
-
E
-
-
Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 8
-
-
R
-
R
-
-
Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 7
-
-
R
-
R
-
-
Optimizing the Selection of First-Line Therapy for Patients with Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement
-
-
J
-
J
-
-
J
-
J
-